Main

April 24, 2006

Ginger M

Interventional Radiology, catheters, Mediport, Cytoxan, Neupogen,
Ginger Miller does it all in Dresden/Columbus, Ohio.

March 19, 2006

Marc Kashinsky

Marc Kashinsky, mantle cell lymphoma survivor.

January 17, 2006

Liquid Chaos

Liquid Chaos chronicles treatment for hodgkins lymphoma.

December 14, 2005

Hodgkins treatments at Sloan Kettering -- Alese Coco

Sloan Kettering offers PDX and SAHA treatments for Alese Coco (journal).

December 09, 2005

lymphoma fora at webmagic

Lymphoma Hodgkin's Lymphoma

November 26, 2005

Cheerful Oncologist

The Cheerful Oncologist says Doctors therefore shouldn’t act shocked when they run across a patient who has lived much longer than expected - it is rude for one thing, and tends to make them look like they really aren’t advocates for the patient.

August 31, 2005

Neulasta and leg pain

(following Neulasta shot fri 1pm)
pain rt leg sat 2-8 pm  2 tylenol
2005 june Sat ~25

NEULASTA

A common adverse effect of chemotherapy, febrile neutropenia can be life-threatening. The FDA has approved Neulasta (pegfilgrastim) to boost production of infection-fighting white blood cells (WBC) in patients with nonmyeloid malignancies who are receiving immunosuppressive anticancer drugs. Administered as a single injection during each chemotherapy cycle, Neulasta has an advantage over Neupogen (filgrastim), the only other drug available for this indication. Neupogen is given daily during chemotherapy.

Although similar to Neupogen, Neulasta has had a polyethylene glycol molecule ("PEG" unit) added to enlarge its filgrastim molecules. This extends the drugs half-life and prolongs its beneficial effects in the body. Drug clearance is regulated by neutrophils, so the drug remains in the blood while the patient needs itwhen he's neutropenic-and clears rapidly when neutrophil levels rise.

In clinical trials, the new drug was well tolerated and safe. The most common adverse reaction was
bone pain, which in most cases responded to nonnarcotic analgesics.

*